Hope TMS and Neuropsychiatric Center 
646 558 5299
Elvin Ruiz M.D.
About Hope TMS
About TMS
For Patients

57 West 57th Street       Suite 808       New York, New York       10019
57 West 57th Street      Suite 808      New York, New York      10019
NeuroStar TMS Therapy is a new treatment cleared by the US Food and Drug Administration (FDA) for patients suffering from depression who have not achieved satisfactory improvement from prior antidepressant treatment. TMS stands for "transcranial magnetic stimulation."

TMS Therapy is a treatment that can be performed in a psychiatrist's office, under his or her supervision, using a medical device called the NeuroStar TMS Therapy system. The typical initial treatment course consists of at least 5 treatments per week over a 4-6 week period, for an average of 20-30 total treatments. Each treatment session lasts approximately 38 minutes.
NeuroStar TMS Therapy is:
  • Non-Invasive, meaning that it does not involve surgery or needles. It does not require any anesthesia or sedation, as the patient remains awake and alert during the treatment
  • Non-Systemic, meaning that it is not taken by mouth and does not circulate in the blood stream throughout the body.This means that there is no Weight Gain, No Loss of Libido or sexual dysfunction, No Drowsiness or Insomnia, No Nausea or Dry Mouth. 
  • Non-Convulsive, meaning that it does not involve the induction of seizures to work
  • No Cognitive Side Effects, such as adverse effects on concentration or memory.
  • No Emotional Side Effects, such as emotional flatness, detachment or apathy.
  • No Increase in Anxiety, Agitation or Suicidality - No Black-Box Warning Issued By FDA Regarding Increase in Suicidality UNLIKE MEDICATIONS

About Transcranial Magnetic Stimulation (TMS)
Through a treatment coil, the TMS system generates highly concentrated, magnetic fields which turn on and off very rapidly. These magnetic fields are the same type and strength as those produced by a magnetic resonance imaging (MRI) machine.

Neurostar® Efficacy
Clinical trials have demonstrated the effectiveness of TMS Therapy in treating patients who have not benefited from prior antidepressant medication. TMS Therapy was studied in adult patients suffering from Major Depressive Disorder, all of whom had not received satisfactory improvement with previous pharmacological treatments. Click on the bottom of the page for TMS Efficacy Data & Research link.

An Effective Option for Treating Major Depressive Disorder
In a study where all patients received active treatment (similar to a real clinical context), following between 1-4 unsatisfactory pharmacological treatment protocols;
  • approximately half of the patients treated with TMS Therapy experienced significant improvement in their depression symptoms. 
  • About a third of the patients treated with TMS Therapy experienced complete symptom relief at the end of six weeks. 

  • Patients treated with TMS also experienced significant improvement in anxiety and physical symptoms (such as appetite changes, aches and pains, and lack of energy) associated with depression.

Additionally, Neuronetics has developed a new tool to use in educating patients on the best practices of treating depression. The Best Practices Treatment Guideline for Depression has been developed to help patients understand TMS Therapy as an option if their first line antidepressant medications stop working. 

This guideline is based on the 2010 APA practice guidelines and NeuroStar TMS Therapy indication for use, which says:

"TMS Therapy is indicated for the treatment of major depressive disorder in adult patients who have failed to achieve satisfactory improvement from prior antidepressant medication at or above the minimal effective dose &duration in the current episode."


Benefits of TMS
​TMS Therapy is a safe treatment which utilizes a technology similar to Magnetic Resonance Imaging (MRI) which has a long-term record of safety.

TMS Therapy is free of side effects typically experienced with antidepressant medications. The most common side effect associated with TMS Therapy is scalp pain or discomfort at or near the treatment location— generally mild to moderate.

In clinical trials, fewer than 5% of patients discontinued treatment with TMS Therapy due to adverse events.

There is a rare risk of seizure with TMS Therapy. The estimated risk of seizure under ordinary clinical use is approximately 1 in 30,000 treatments.
Other conditions that have responded Positively to TMS Therapy include: 
  • Anxiety
  • Aphasia
  • Bipolar Disorder/Depression
  • Fibromylagia
  • PTSD
  • Tinnitus
  • Hallucinations

The treatment coil is applied to the head above the left prefrontal cortex. This part of the brain is involved with mood regulation, and therefore is the location where the magnetic fields are focused. These magnetic fields do not directly affect the whole brain; they only reach about 2-3 centimeters into the brain directly beneath the treatment coil. As these magnetic fields move into the brain, they produce very small electrical currents. These electrical currents activate cells within the brain which are thought to release neurotransmitters like serotonin, norepinephrine, and dopamine to treat depression